Weight-loss experts reveal their major predictions for 2026, from advanced GLP-1 treatments to AI-driven personalized therapy ...

Obesity is a growing national health crisis, with nearly 40% of U.S. adults affected and about 10% having a severe form of ...

Eli Lilly and Nimbus Therapeutics have entered into a multiyear collaboration and exclusive licensing agreement to develop an ...

A phase 1 study to evaluate safety, tolerability, bioavailability, pharmacokinetics, and weight loss of GLP-1/GLP-2 dual ...

Over 27 percent of adults worldwide with obesity qualify for GLP-1 weight loss medicines but access remains unequal.

The research, published in the British Medical Journal on Thursday, adds to a growing body of evidence that suggests ...

UK experts are warning that access to new weight-loss drugs could depend more on wealth than medical need. Strict NHS ...

Beneficial pediatric obesity treatment response was associated with a reduced risk of obesity-related events in young adults, a nationwide prospective cohort study in Sweden showed. Compared with poor ...

Obesity has traditionally been considered a risk factor for various diseases. However, it is increasingly recognized as a disease by medical societies and governments. The 2020 Canadian Adult Obesity ...

When children with obesity undergo weight-loss treatment, the effects have repercussions later in life and the risk of serious health problems and premature death is lower as they reach young ...

Researchers at Mass General Brigham reveal that nearly 70% of U.S. adults are obese according to a study that was published ...